AN2 Therapeutics, Inc. Logo

AN2 Therapeutics, Inc. (ANTX)

NASDAQ

Currency in USD
5.05
+0.15 (+3.06%)

Closed

Sep 18, 2026

Day's Range

4.80
5.15

52 wk Range

1.00
7.19

Recommendations - ANTX - AN2 Therapeutics, Inc.

Analyst Ratings - ANTX - AN2 Therapeutics, Inc.

Analyst ratings

DateFirmActionRating
Jul 20, 2026GuggenheimInitiates coverageBuy
May 14, 2026Leerink PartnersUpgradeMarket Perform → Outperform
May 05, 2025JMP SecuritiesMaintainsOutperform
Mar 26, 2025Citizens Capital MarketsReiteratesOutperform
Feb 25, 2025Citizens Capital MarketsReiteratesOutperform
Feb 03, 2025JMP SecuritiesReiteratesOutperform
Nov 19, 2024JMP SecuritiesReiteratesOutperform
Nov 18, 2024TD CowenDowngradeBuy → Hold
Aug 09, 2024JMP SecuritiesMaintainsOutperform
Jul 03, 2024Leerink PartnersUpgradeMarket Perform → Outperform
Items per row:

Estimates - ANTX - AN2 Therapeutics, Inc.

Estimate momentum

Next quarter · How the consensus estimate has moved over the last 90 days.

90 days ago-0.25
Now-0.23
Change+6.0%
Revised last month0/1

Growth estimates

Current quarter-14.3%
Next quarter+31.0%
Current year+22.8%
Next year+10.6%

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter2-0.25-0.24-0.23-0.21
Next quarter2-0.20-0.20-0.20-0.29
Current year2-0.93-0.90-0.86-1.16
Next year2-0.86-0.80-0.74-0.90

Earnings History - ANTX - AN2 Therapeutics, Inc.

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-08-11After Hours-0.24-0.18+0.06‪-25.00%‬
2026-05-11After Hours-0.23-0.29-0.06‪+26.09%‬
2026-03-17After Hours-0.24-0.29-0.05‪+20.83%‬
2026-02-17After Hours0.600.69+0.09‪+15.00%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.